Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDGFRB | P09619 | 1/20 | 0.65 |
| ▸ | NTRK1 | P04629 | 5/20 | 0.57 |
| ▸ | NTRK3 | Q16288 | 2/20 | 0.57 |
| ▸ | NTRK2 | Q16620 | 2/20 | 0.57 |
| ▸ | RET | P07949 | 3/20 | 0.50 |
| ▸ | KCNH2 | Q12809 | 2/20 | 0.48 |
| ▸ | PDPK1 | O15530 | 9/20 | 0.47 |
| ▸ | AKT1 | P31749 | 7/20 | 0.47 |
| ▸ | MTOR | P42345 | 7/20 | 0.47 |
| ▸ | EGFR | P00533 | 2/20 | 0.45 |
| ▸ | ERBB2 | P04626 | 2/20 | 0.45 |
| ▸ | ERBB3 | P21860 | 2/20 | 0.45 |
| ▸ | TEK | Q02763 | 2/20 | 0.45 |
| ▸ | ERBB4 | Q15303 | 2/20 | 0.45 |
| ▸ | FLT3 | P36888 | 1/20 | 0.45 |
| ▸ | MET | P08581 | 1/20 | 0.44 |
| ▸ | AXL | P30530 | 1/20 | 0.44 |
| ▸ | AURKA | O14965 | 2/20 | 0.43 |
| ▸ | GSK3B | P49841 | 2/20 | 0.43 |
| ▸ | MARK1 | Q9P0L2 | 2/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1941086 | 0.93 | PDGFRB (0.75) | PDGFRBNTRK1NTRK3NTRK2RET | |
| SCHEMBL1939912 | 0.92 | PDGFRB (0.62) | PDGFRBNTRK1NTRK3NTRK2RET | |
| SCHEMBL1939745 | 0.92 | PDGFRB (0.66) | PDGFRBNTRK1NTRK3NTRK2RET | |
| SCHEMBL1941408 | 0.92 | PDGFRB (0.68) | PDGFRBNTRK1NTRK3NTRK2RET | |
| SCHEMBL1940511 | 0.92 | PDGFRB (0.66) | PDGFRBNTRK1NTRK3NTRK2RET | |
| SCHEMBL1941573 | 0.91 | PDGFRB (0.67) | PDGFRBNTRK1NTRK3NTRK2RET | |
| SCHEMBL1940718 | 0.91 | PDGFRB (0.67) | PDGFRBNTRK1NTRK3NTRK2RET | |
| SCHEMBL1942434 | 0.90 | NTRK1 (0.70) | PDGFRBNTRK1NTRK3NTRK2RET | |
| SCHEMBL1940342 | 0.90 | NTRK1 (0.61) | PDGFRBNTRK1NTRK3NTRK2RET | |
| SCHEMBL1940531 | 0.90 | PDGFRB (0.63) | PDGFRBNTRK1NTRK3NTRK2RET |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1578751-B1 | PYRROLOPYRIMIDINE DERIVATIVES | PFIZER PROD INC (US) | 2011-06-15 | — | — | EP | disclosed |
| US-7271262-B2 | Pyrrolopyrimidine derivatives | PFIZER INC (US) | 2007-09-18 | — | — | US | disclosed |
| CN-1726218-A | Pyrrolopyrimidine derivatives | PFIZER PROD INC (US) | 2006-01-25 | — | — | CN | disclosed |
| US-20050037999-A1 | Pyrrolopyrimidine derivatives | PFIZER INC | 2005-02-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050037999-A1 | Pyrrolopyrimidine derivatives | CCNA1, CCNT1, TP53 | PDGFRB 2465/4885NTRK1 4135/4885NTRK3 4212/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.